Skip to main content

Continua to Present at Continuous Manufacturing Forum

An Open Platform for Dialogue on Technological Advances
Pharmaceutical Continuous Manufacturing

September 22-23 | Princeton, NJ

Continua’s Anthony DeBiase will be speaking on day two of the forum. His session will cover a vendor-agnostic connectivity strategy that simplifies integration across historians, MES, and control systems while improving commissioning speed, operational flexibility, and data integrity. It will include insights from a real-world deployment and a discussion around how Continua evaluated modularity, scalability, and regulatory readiness along the way.

The Continuous Manufacturing Forum serves as a catalyst for compelling conversations, bringing together key opinion leaders in biotech and pharma. It unites executive leadership, directors, senior scientists, consultants, and a closely-knit network of CDMOs, academic leaders, and equipment providers.

Anthony DeBiase
Director, Digital PD
& Clinical Manufacturing
Continua

LEARN MORE ABOUT THE EVENT
MORE INSIGHTS & STORIES

AI-Enabled Data Integration and Quality Management for Agile Pharmaceutical Manufacturing

Learn how we’ve built a structured, real-time data foundation that speeds up tech transfers, reduces QA workload, and aligns with FDA initiatives.

Implementing Manufacturing Workflow Automation

Embracing digital transformation in life sciences manufacturing organizations can enhance overall operational efficiency.

The Next Step in Your Digital Strategy

Learn how to assess and build your DX strategy with a Digital Transformation Maturity Assessment.

The Ideal Architecture for Digital Transformation

Know the ‘current state’ and ‘future state’ of your business in real time with contextualized data from an enterprise-wide data hub.

The Business Case for Digital Transformation

Digital Transformation can unlock significant value across the entire supply chain and throughout the factory network.

Augmenting an MES

Bringing large amounts of data into your business systems requires the flexibility, security, and growth potential of a Unified Namespace ecosystem.

Integrating Lab Automation Systems

Learn how we integrated Nova FLEX cell culture analysis data with this pharma company’s plant control system to automate required actions.

Monitoring High-Value R&D Materials

This biotech company now monitors and tracks its R&D materials throughout the earliest stages of drug development using a UNS platform.

MES Data Informs Analytics

Explore several ways to extract MES data to support analytics: from hiring an MES engineer to querying the MES recipe, to creating a Unified Namespace.

Ideal Unified Namespace Pilots

Examples: Continuous Process Verification with batch-to-batch comparisons at different locations and Machine Learning with data from multiple systems.